As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.
7 Analysts have issued a HCW Biologics Inc forecast:
7 Analysts have issued a HCW Biologics Inc forecast:
Mar '25 |
+/-
%
|
||
Revenue | 1.45 1.45 |
63%
63%
|
|
Gross Profit | 0.35 0.35 |
70%
70%
|
|
EBITDA | -23 -23 |
18%
18%
|
EBIT (Operating Income) EBIT | -23 -23 |
17%
17%
|
Net Profit | -24 -24 |
11%
11%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
HCW Biologics, Inc. operates as a holding company which engages in the research and development of immunotherapies. It focuses on cancer and aging-associated diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.
Head office | United States |
CEO | Hing Wong |
Employees | 36 |
Founded | 2018 |
Website | hcwbiologics.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.